Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match

June 29, 2025 updated by: Filipe Silvano Pinto Maia, University of Maia

Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match on Elite Youth Soccer Players

This study aims to identify the effects of the use of intermittent pneumatic compression on the recovery kinetics following an official soccer match, in comparision with a placebo condition. Participants will perform neuromuscular tests (ie, cmj, low-frequency fatigue), respond to perception scales (RPE, perceived fatigue, soreness, sleep), and biochemical tests (CK analysis). These assessments will be carried out before the match, 30 minutes post match, at the 24th and 48th hour.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Portugal
      • Maia, Portugal
        • Universidade da Maia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • elite soccer players

Exclusion Criteria:

  • absent from injuries
  • playing less than 70 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intermittent pneumatic compression
30 minutes of intermittent pneumatic compression at 200mmHg
Device: Intermittent pneumatic compression
Following a soccer match, athletes will be enrolled in a recovery treatment: placebo intervention or intermittent pneumatic compression. Participants will be randomly assigned to each group. Neuromuscular tests (cmj) and perceptual questionnaires (hooper index) will be conducted.
Placebo Comparator: Placebo
A hydrant cream on a pad will be placed on participants quadriceps stating that they are using an inovative recovery cream.
Device: Intermittent pneumatic compression
Following a soccer match, athletes will be enrolled in a recovery treatment: placebo intervention or intermittent pneumatic compression. Participants will be randomly assigned to each group. Neuromuscular tests (cmj) and perceptual questionnaires (hooper index) will be conducted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement jump height
Time Frame: 30 minute, 24 hour, 48 hour
Height measure using CMJ test
30 minute, 24 hour, 48 hour
low-frequency fatigue
Time Frame: baseline, 30 minute, 24 hour, and 48 hour
LFF measured using Myocene (Liege, Belgium)
baseline, 30 minute, 24 hour, and 48 hour
Hooper index
Time Frame: baseline, 30 minute, 24 hour, and 48 hour
Application of the hooper index questionnaire
baseline, 30 minute, 24 hour, and 48 hour
creatine-kinase
Time Frame: baseline, 24 hour, and 48 hour
Muscle damage asses using the biomarker CK
baseline, 24 hour, and 48 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Maia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

May 29, 2025

Study Completion (Actual)

June 29, 2025

Study Registration Dates

First Submitted

October 2, 2024

First Submitted That Met QC Criteria

October 10, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2025

Last Update Submitted That Met QC Criteria

June 29, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PDFM_004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe